Alerts will be sent to your verified email
Verify Email
VENMAX
|
Venmax Drugs&Pharma
|
Hamps Bio
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-46.46 % | 14.19 % | 8.38 % |
|
5yr average Equity Multiplier
|
0.08 | 2.36 | 1.27 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 1.18 | 1.23 |
|
5yr Avg Net Profit Margin
|
-19.62 % | 5.23 % | 5.43 % |
|
Price to Book
|
4.78 | 2.5 | 2.04 |
|
P/E
|
0.0 | 74.57 | 21.34 |
|
5yr Avg Cash Conversion Cycle
|
288.55 Days | 74.76 Days | 74.52 Days |
|
Inventory Days
|
5.2 Days | 53.3 Days | 35.08 Days |
|
Days Receivable
|
430.69 Days | 59.7 Days | 31.6 Days |
|
Days Payable
|
141.12 Days | 80.45 Days | 42.7 Days |
|
5yr Average Interest Coverage Ratio
|
-260.56 | 3.45 | 24.46 |
|
5yr Avg ROCE
|
-47.43 % | 18.02 % | 11.48 % |
|
5yr Avg Operating Profit Margin
|
-65.91 % | 14.19 % | 6.66 % |
|
5 yr average Debt to Equity
|
-0.45 | 0.99 | 0.09 |
|
5yr CAGR Net Profit
|
-42.57 % | 20.11 % | 0.95 % |
|
5yr Average Return on Assets
|
199.45 % | 6.19 % | 6.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.13 % | 71.99 % | 49.96 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.64 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venmax Drugs&Pharma
|
Hamps Bio
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|